LIVE WEBINAR
Wednesday, August 13th | 2pm ET
Duration: 1 hour
Can't make the live date? Register and we'll send you a link to the recording.

The biosimilar market is projected to reach $73 billion by 2030, but manufacturing these complex biologics presents challenges. Pharma companies must optimize processes, meet strict timelines, and reduce costs in a competitive landscape. As bioprocessing evolves, manufacturers must evaluate scale-up and scale-out strategies to maintain efficiency and manage risk in a market where "the process is the product."

This webinar from Cytiva explores navigating these challenges and making informed decisions about manufacturing scenarios that impact cost of goods. Industry experts share insights on process economics and strategies to stay competitive while meeting market demands. Key topics include:

• How scale-out scenarios impact cost of goods and factors to consider when scaling up or out
• Why titer increases are a powerful lever for reducing costs
• Balancing process optimization with risk management when adopting advanced bioprocessing technologies

SPEAKERS

Henrik Ihre, Ph.D.
​Business Leader – Next Generation Resins and Technologies
Cytiva
 

Niklas Jungnelius
Process Modeling Leader
Cytiva